Surims Ltd Logo
ADC Biotechnology Ltd Logo  
Basic Profile
If you'd like to claim this company profile for ADC Biotechnology Ltd, please Contact Us.

ADC Biotechnology Ltd News

The latest news, announcements and press releases from ADC Biotechnology Ltd.

08th April 2021

Sterling Pharma Solutions acquires ADC Bio

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced the acquisition of ADC Biotechnology (ADC Bio), a UK based bioconjugation development services business specialising in antibody drug conjugates (ADCs).

This follows an announcement by Sterling in December of a strategic investment into the ADC Bio business, with a view to acquisition in 2021.

Read the full story »
03rd December 2020


We are pleased to announce that Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions (Sterling) has made a new strategic partnership with our Company.

The partnership will see Sterling make a significant investment in the business with a view to acquiring ADC Biotechnology in Q1 next year, subject to due diligence.

The businesses will work together to develop an integrated service offering for existing and potential customers, which combines ADC Bio’s expertise with Sterling’s high potency small molecule expertise.

Kevin Cook, CEO at Sterling, said: “This partnership is a really exciting one for both businesses. It will enable continued innovation around this fast-developing science, and in the future we hope that our combined expertise and targeted investment will be a strong competitive force in the race to find the latest generation of drugs in the oncology area.

“Sterling has always been, and will continue to be, focused on the services we can provide to our customers, to ensure they are ahead of the innovation curve and can develop the latest scientific breakthroughs to deliver better drugs for their patients. This partnership is a perfect example of this; some of the finest experts working together to achieve bigger and better things.”

Alan Raymond, Executive Chairman of ADC Bio, added: “The team at ADC Bio have been at the forefront of antibody drug bioconjugation and process development, supporting important advances in oncology with our clients in recent years.  This strategic partnership will allow us to further develop this service with significant investment in the right areas of the business, which is great news for our employees and our customers.  We are looking forward to working with the team at Sterling.”

20th December 2017

ADC contractor moves forward with U.K. production plant

With the focus of many companies on developing new cancer drugs using antibody drug conjugates (ADCs), contractor ADC Biotechnology is moving quickly to get a manufacturing facility built in Wales to produce its new ADCs.

The U.K. biotech said today that it has a contract with engineering firm WHP to build it $11 million, 21,325-square-foot facility at its site in Deeside, North Wales. The first phase is expected to be completed by December of 2018 and will support the production of all clinical phases and small-scale commercial manufacture of its ADCs.
Read the full story »

Claim This Profile

This is the News section of the company profile page for ADC Biotechnology Ltd on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.

ADC Biotechnology Ltd company details, activities, contacts and reviews.
ADC Biotechnology Ltd partnership and licensing opportunities.
ADC Biotechnology Ltd latest news, announcements and press releases.
ADC Biotechnology Ltd documents, images and videos.
ADC Biotechnology Ltd global factories, offices and locations.
ADC Biotechnology Ltd legal and financial information.

About Us

Surims Ltd is a consultancy established in 2003 supporting companies in the identification, qualification and management of quality vendors and suppliers in ingredients and formulations.

The Pharmaceutical Services Directory supports the identification and on-boarding of quality suppliers and also incorporates software features that manage relationships between suppliers and their customers. These include the building and deployment of questionnaires and assessments, electronic signatures and sign-offs and project management between vendor/partner and customer.

Access to the features and software is available on a 'pay as you go' basis, or a customised version can be licensed for your company for its own on-boarding and supplier management activities. Further information on our software services can be found at


Get in Touch

The Pharmaceutical Services Directory


© 2021 Surims Ltd | All Rights Reserved.